Search

for
Search:

GlossaryEtanercept

biologic drug inhibiting TNF to reduce inflammation in autoimmune diseases

Etanercept is a biologic medication that works by inhibiting tumor necrosis factor (TNF), a substance in the body that causes inflammation. It is commonly used to treat autoimmune conditions like rheumatoid arthritis and psoriasis, where the immune system mistakenly attacks the body's own tissues.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 354 results

research Recurrence of Alopecia Areata in a Patient Receiving Etanercept Injections

75 citations , June 2005 in “Archives of Dermatology”

Etanercept may not prevent alopecia areata from coming back.

research Onset of Lichen Planopilaris During Treatment with Etanercept

39 citations , March 2008 in “British Journal of Dermatology”

Etanercept may cause lichen planopilaris, so doctors should be cautious.

research Successful Etanercept Therapy in Therapy-Refractory Acrodermatitis Continua Suppurativa Hallopeau

20 citations , May 2007 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft”

Etanercept effectively treated a severe skin condition when other treatments failed.

research Psoriatic Onychopachydermoperiostitis: Improvement with Etanercept

7 citations , August 2005 in “British Journal of Dermatology”

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

research Acrodermatitis Continua Resistant to Etanercept: Therapeutic Challenge and Unfortunate Outcome

6 citations , June 2008 in “Journal of the European Academy of Dermatology and Venereology”

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

View more "etanercept" in research →

Community Join

1 / 1 results

community Rejected for the 2nd time for the VDPHL01 Clinical Trials (believe it or not!)

in Chat 12 upvotes 5 months ago

The user was rejected from participating in a clinical trial for an extended-release oral Minoxidil due to having rheumatoid arthritis, despite initially being accepted. They had stopped using Dutasteride and Minoxidil to qualify but continued using other treatments like RU58841 and red light therapy.